These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38027676)

  • 1. Pharmacokinetic and pharmacodynamic drug-drug interaction of Nomilin with atorvastatin in hyperlipidemic mice.
    Ding Y; Guan H; Yan Y; Chen Y; Huang C
    Heliyon; 2023 Nov; 9(11):e22016. PubMed ID: 38027676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences in the drug-drug interaction between atorvastatin and cyclosporine: In vivo study using a stable isotope-IV method in rats and dogs.
    Minami K; Higashino H; Kataoka M; Yamashita S
    Eur J Pharm Sci; 2020 Sep; 152():105409. PubMed ID: 32512140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-drug interaction study to assess the effects of atorvastatin co-administration on pharmacokinetics and anti-thrombotic properties of cilostazol in male Wistar rats.
    Vats R; Varanasi KV; Arla R; Veeraraghvan S; Rajak S
    Biopharm Drug Dispos; 2012 Nov; 33(8):455-65. PubMed ID: 22936637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multidose cilostazol on pharmacokinetic and lipid profile of atorvastatin in male Wistar rats.
    Vats R; Varanasi KV; Arla R; Veeraraghavan S; Rajak S; Murthy AN
    J Pharm Pharmacol; 2012 Nov; 64(11):1638-45. PubMed ID: 23058051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: Application in a clinical pharmacokinetic study of single oral dose.
    Cestari RN; Rocha A; Marques MP; de Oliveira RDR; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121766. PubMed ID: 31450089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats.
    Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP
    J Control Release; 2017 May; 254():10-22. PubMed ID: 28344015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous LC-MS/MS analysis of simvastatin, atorvastatin, rosuvastatin and their active metabolites for plasma samples of obese patients underwent gastric bypass surgery.
    El-Zailik A; Cheung LK; Wang Y; Sherman V; Chow DS
    J Pharm Biomed Anal; 2019 Feb; 164():258-267. PubMed ID: 30396053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats.
    Ding C; Li Y; Li X; Meng L; Fu R; Wang X; Li Y; Ma Y; Dong Z
    Pharm Biol; 2022 Dec; 60(1):185-194. PubMed ID: 35001796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose atorvastatin improves vascular endothelial function in patients with leukoaraiosis.
    Xue J; Wu Z; Gong S; Qin S; Gu A
    J Clin Lab Anal; 2020 Mar; 34(3):e23081. PubMed ID: 32154613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of atherosclerotic plaques and intraplaque neovascularization using contrast-enhanced ultrasound after treatment with atorvastatin in rabbits.
    Liu HY; Zhou J; Tong H; Tang Y; Wang XF; Zhou QC
    Biomed Pharmacother; 2017 Aug; 92():277-284. PubMed ID: 28551548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a UPLC-MS/MS method for the simultaneous determination of atorvastatin, 2-hydroxy atorvastatin, and naringenin in rat plasma and its application to pharmacokinetic interaction studies.
    Li W; Xu X; Wang S; Li Y; Zhang Y; Zhang T
    Biomed Chromatogr; 2023 Jan; 37(1):e5515. PubMed ID: 36189913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Gegenqinlian Decoction on Pharmacokinetics and Pharmacodynamics of Atorvastatin Calcium in Hyperlipidemic Rats.
    Cui M; Zhu F; Yin Y; Sui Y; Yan X; Chen T
    Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):117-126. PubMed ID: 34855161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Proof-of-Concept for a Hypolipidemic Brown Trout Model.
    Lourenço T; Rocha E; Gonçalves JF; Rocha MJ; Madureira TV
    Toxics; 2024 Mar; 12(3):. PubMed ID: 38535952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Orally Administered Atorvastatin on Plasma Lipid and Biochemistry Profiles in Hypercholesterolemic Hispaniolan Amazon Parrots (
    Robertson JA; Guzman DS; Graham JL; Stanhope KL; Douglas JM; Havel PJ; Beaufrère H; Knych H; Tully TN; Paul-Murphy JR
    J Avian Med Surg; 2020 Mar; 34(1):32-40. PubMed ID: 32237680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin.
    Sumsakul W; Plengsuriyakarn T; Na-Bangchang K
    BMC Pharmacol Toxicol; 2016 Nov; 17(1):50. PubMed ID: 27839515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose supplementation with natural α-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigs.
    Podszun MC; Grebenstein N; Hofmann U; Frank J
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):452-8. PubMed ID: 23200775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia.
    Ballantyne CM; Lipka LJ; Sager PT; Strony J; Alizadeh J; Suresh R; Veltri EP
    Int J Clin Pract; 2004 Jul; 58(7):653-8. PubMed ID: 15311720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.